Table of Contents
Trial overview
This article covers one interventional study of Zanamivir in very young children with influenza. The trial was completed and enrolled 11 participants.[1]
The study focused on hospitalized neonates and infants under 6 months of age with confirmed complicated influenza infection.[1]
Who participated
The target population was neonates, meaning babies in the first 28 days of life, and infants under 6 months of age.[1]
All participants had confirmed complicated influenza infection and were hospitalized, so this was a very specific and medically fragile group.[1]
What was studied
Researchers studied intravenous Zanamivir, given as Dectova 10 mg/mL solution for infusion in the trial record.[1]
The main goal was to evaluate single-dose and multiple-dose pharmacokinetics, which means how the treatment moves through the body over time.[1]
The trial also assessed safety and tolerability, meaning whether the treatment could be given without unacceptable problems and how well the children could handle it.[1]
In addition, the study explored clinical outcomes during treatment, so the researchers looked beyond blood measurements to see what happened clinically in these patients.[1]
Outcomes measured
The primary outcomes were AUC, Cmax, clearance, and terminal half-life.[1]
AUC means area under the concentration-time curve and shows total exposure to the treatment in the blood.[1]
Cmax is the highest blood level reached after treatment.[1]
Clearance shows how quickly the body removes the treatment, and terminal half-life shows how long it takes the blood level to drop by half near the end of the process.[1]
Study design and phase
The study was a Phase 2 trial, which is often used to gather more information about safety and early effectiveness in a defined patient group.[1]
It was also an open-label, single-arm study, meaning everyone knew what treatment was being given and there was no comparison group listed in the trial record.[1]
Because the trial is completed, the planned research steps have already been finished.[1]
